2015-01-27 15:08

 

Several pharmaceutical companies have been "occupied" EU GMP inspection defects where

 

CNDSN January 27th news (Xinkang circles) defect list throughout several EU GMP check failed, the hardware part almost no, mainly lies in the deficiency of software.

Recently, several Chinese pharmaceutical companies for the EU GMP inspection failure, caused great shock in the domestic pharmaceutical industry, including Taishan City Chemical Pharmaceutical Co. Ltd, Zhejiang Apeloa Biological Pharmaceutical Co. Ltd, Fujian Nanfang pharmaceutical Limited by Share Ltd...... Especially in North China Pharmaceutical "fall", caused widespread discussion in the dandelion Pharmaceutical Technology Forum, particularly revealing.

"It seems to be more and more strict!" "The accumulation of domestic pharmaceutical enterprises for many years of exposure to the world" vices "serious deficiencies are the data, records are not true, Chinese medicine is a microcosm of China Pharma ah!" "Domestic enterprises are like this, China pharmaceutical integral atmosphere is false, no one can withstand check" "environment, need from Nenoue Shi." "The data fraud FDA can't stand, in fact, domestic inspection is the same", even someone put forward "the drug administration department should linkage, all international inspection be shot, domestic GMP certificate shall be revoked. Outside the Box, jade."

The defect list throughout several EU GMP check failed practices, the hardware part almost no, mainly lies in the deficiency of software components: data management is not sufficient, inaccurate data, analysis report fraud, record of changing content, re copying records, many date and signature is not consistent. Deficiency of QC Laboratory of electronic data security, integrity, no access control, no audit trail, no delete data limitations etc.. Quality management system defects, data verification, file management, deviation handling etc.. Including computer validation, computer management.

Since the implementation of the new version of GMP certification, also some people made a statistical analysis, the defects found in plant facilities, the defects of the 15%, quality system, file management, validation management, agency personnel more than 55%, production management, equipment management and other aspects accounted for 30%.

Therefore, I think before we are always in a point of criticism: "Premium software", now I don't know "what software is insufficient to fill?" "Management issues what fill?"

A single edged eyelid beauty to pull the eyelid, which is called "the lack of hardware hardware fill" icing on the cake.

A cleft children to do cleft lip repair, which is called "the lack of hardware hardware fill" timely help.

Old XP computer to run win8, only to streamline and optimize the system, which is called "premium software".

Jam "City purchase limit, limit line, single", this is called "premium software".

In short, a lot of congenital defects, temporarily unable to resolve, but not enough to have a fatal risk, or solve the cost is too high and the price is too low, relying on the "optimize work process, improve the operation of SOP" and other measures can reduce the risk in acceptable range, so why not?

Just imagine, if an amputee family had no money, he will go to the prosthetic? If a woman no money at home, she will go to Korea to have plastic surgery? If a rich man, and he will use old computers installed streamlined system? If a city planning reasonable, traffic developed, also need to purchase limit, limit line?

In the pharmaceutical industry, in the process of GMP implementation, the vast majority of people are very disgusted "Premium software" this word, they think this sentence itself is the company does not want to increase the "hardware" input, or the project implementation stage did not do a good job in the "hardware", but also very reluctant to hardware rectification excuse.

In fact, the current domestic GMP implementation level in terms of hardware has been greatly improved, although the equipment innovation ability of pharmaceutical in China is not strong, industry overall technical level is not high, the low level of imitation overflowed, integration, automation level need to be strengthened, but as the pharmaceutical equipment industry repeatedly reshuffle, some medicine machine tap enterprise integration of high-quality assets, some medicine machine enterprises professional level, except the part of poor economic conditions of the pharmaceutical companies choose medicine machine equipment quality low, the level of pharmaceutical equipment in our country has been fully able to follow the pace of the whole pharmaceutical GMP levels, but is the industry the concept of GMP, software documentation, quality management...... Aspects of the backward, causing a serious risk of pharmaceutical GMP compliance and drug quality.

Many pharmaceutical companies, facility construction, equipment selection, can say is the domestic first-class, and even international first-class, but due to the GMP concept, the consciousness of quality management is backward, the formation of software documentation, the second of the second of the quality management system, finally some pharmaceutical companies spend heavy gold to transplant a first-class software files only in order to cope with a GMP check, get certificate, fine, or because of the quality of personnel, management level, cost pressure...... Will be first-class software on the shelf, still go its own way to repeat the three flow management level.

"First-class hardware, the second of the software, the flow of the three management", this may is the fundamental reason for many companies of EU GMP check failed, some defects which, in the domestic GMP examination should also meet the eye everywhere, there may be differences between Chinese and foreign GMP inspection and inspector of aesthetic is different, what one sees and hears, do not weigh the same.

"First-class hardware, the second of the software, the flow of the three management", the deep-seated reasons behind, more worth to find and interpret! *

(original title: many companies have been "occupied" EU GMP inspection defects where?)

Editor: Blue